360
Participants
Start Date
February 23, 2020
Primary Completion Date
December 31, 2027
Study Completion Date
December 31, 2029
SABR boost and de-escalated chemoradiation
Stereotactic body radiotherapy boost to the gross tumor volume to a dose of 14 Gy in 2 fractions, followed by cisplatin-based chemoradiation to a dose of 40 Gy in 20 fractions
Standard chemoradiation
Standard Cisplatin-based chemoradiation to a dose of 70 Gy in 33 fractions
RECRUITING
London Health Sciences Center, London
RECRUITING
Centre Hospitalier de l'Université de Montréal, Montreal
M.D. Anderson Cancer Center
OTHER
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
OTHER
Jewish General Hospital
OTHER
Centre hospitalier de l'Université de Montréal (CHUM)
OTHER